000

INBODY

No trades
See on Supercharts
Market capitalization
‪353.68 B‬KRW
‪36.72 B‬KRW
‪170.35 B‬KRW
‪8.67 M‬
Beta (1Y)
0.80

About INBODY

Headquarters
Seoul
Website
Employees (FY)
325
Founded
1996
ISIN
KR7041830001
FIGI
BBG000F00298
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. Its products include body composition analyzers, automatic shpygmomanometers, and extensometers. The company was founded by Cha Ki-Chul on May 15, 1996 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 041830 is 28750 KRW — it has increased by 4.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange INBODY stocks are traded under the ticker 041830.
INBODY is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
041830 stock is 7.12% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is INBODY there?
One year price forecast for INBODY has a max estimate of 39000 KRW and a min estimate of 37000 KRW.
041830 earnings for the last quarter are 459.00 KRW whereas the estimation was 344.00 KRW which accounts for 33.43% surprise. Estimated earnings for the next quarter are 406.00 KRW. See more details about INBODY earnings.
INBODY revenue for the last quarter amounts to ‪44.80 B‬ KRW despite the estimated figure of ‪44.10 B‬ KRW. In the next quarter revenue is expected to reach ‪42.95 B‬ KRW.
Yes, you can track INBODY financials in yearly and quarterly reports right on TradingView.
041830 stock has risen by 5.31% compared to the previous week, the month change is a 0.17% rise, over the last year INBODY has showed a 3.36% decrease.
041830 net income for the last quarter is ‪7.28 B‬ KRW, while the quarter before that showed ‪12.05 B‬ KRW of net income which accounts for −39.63% change. Track more INBODY financial stats to get the full picture.
Today INBODY has the market capitalization of ‪358.89 B‬, it has decreased by 7.73% over the last week.
Yes, 041830 dividends are paid annually. The last dividend per share was 350.00 KRW. As of today, Dividend Yield (TTM)% is 1.27%. Tracking INBODY dividends might help you take more informed decisions.
INBODY dividend yield was 1.38% in 2023, and payout ratio reached 12.42%. The year before the numbers were 1.49% and 11.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 041830 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INBODY stock right from TradingView charts — choose your broker and connect to your account.
041830 reached its all-time high on Jan 7, 2016 with the price of 59600 KRW, and its all-time low was 700 KRW and was reached on Nov 23, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 325.00 employees. See our rating of the largest employees — is INBODY on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INBODY technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INBODY stock shows the buy signal. See more of INBODY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on INBODY future price: according to them, 041830 price has a max estimate of 39000.00 KRW and a min estimate of 37000.00 KRW. Read a more detailed INBODY forecast: see what analysts think of INBODY and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INBODY EBITDA is ‪44.26 B‬ KRW, and current EBITDA margin is 25.98%. See more stats in INBODY financial statements.